Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Personalized Medicine
|
April 28, 2023
Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
Ivo I de Vos, Henk B Luiting, Monique J Roobol
European Urology
|
November 2, 2023
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Ivo I de Vos, Sebastiaan Remmers, Renée Hogenhout, et al.
European Urology
|
April 7, 2023
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer
Ivo I de Vos, Annick Meertens, Renée Hogenhout, et al.
European Urology Oncology
|
September 10, 2023
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life
Renée Hogenhout, Sebastiaan Remmers, Marlies E van Slooten-Midderigh, et al.
European Urology Open Science
|
August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
Renée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Oncology
|
November 27, 2024
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Ivo I de Vos, Charlotte Rosenstand, Renée Hogenhout, et al.
European Urology Open Science
|
April 14, 2025
Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors
Lisa J Kroon, Ivo I de Vos, Charlotte F Kweldam, et al.
JAMA Network Open
|
January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance
Ivo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
Translational Andrology and Urology
|
March 14, 2023
Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator
Ivo I de Vos, Frank-Jan H Drost, Leonard P Bokhorst, et al.
European Urology Open Science
|
December 6, 2024
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data
Sebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Personalized Medicine
|
April 28, 2023
Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
Ivo I de Vos, Henk B Luiting, Monique J Roobol
European Urology
|
November 2, 2023
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Ivo I de Vos, Sebastiaan Remmers, Renée Hogenhout, et al.
European Urology
|
April 7, 2023
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer
Ivo I de Vos, Annick Meertens, Renée Hogenhout, et al.
European Urology Oncology
|
September 10, 2023
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life
Renée Hogenhout, Sebastiaan Remmers, Marlies E van Slooten-Midderigh, et al.
European Urology Open Science
|
August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
Renée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Oncology
|
November 27, 2024
Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Ivo I de Vos, Charlotte Rosenstand, Renée Hogenhout, et al.
European Urology Open Science
|
April 14, 2025
Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors
Lisa J Kroon, Ivo I de Vos, Charlotte F Kweldam, et al.
JAMA Network Open
|
January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance
Ivo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
Translational Andrology and Urology
|
March 14, 2023
Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator
Ivo I de Vos, Frank-Jan H Drost, Leonard P Bokhorst, et al.
European Urology Open Science
|
December 6, 2024
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data
Sebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, et al.
Page
of 2